Frontotemporal Dementia Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Frontotemporal Dementia Market is segmented By Disease Type (Behavioral variant FTD, Primary Progressive Aphasia, FTD with Motor Neuron Disease), By T....
Frontotemporal Dementia Market Size
Market Size in USD
CAGR5.9%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 5.9% |
| Market Concentration | High |
| Major Players | Alector, Transposon Therapeutics, AviadoBio, Vesper Bio, GSK |
please let us know !
Frontotemporal Dementia Market Analysis
The Global Frontotemporal Dementia Market is estimated to be valued at USD 12.19 Billion in 2024 and is expected to reach USD 18.21 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031. The rising prevalence of Frontotemporal Dementia around the world due to an aging global population as well as improving diagnostics is driving the growth of this market.
The market is witnessing positive growth trends with increased research and development activities focusing on development of new biomarkers and diagnostic technologies for early diagnosis. Several ongoing clinical trials evaluating new drugs for disease modifying therapy are also supporting market growth. Improving awareness about the illness as well as availability of several promising pipeline drugs will continue to provide opportunities for the Frontotemporal Dementia market in the forecast period.